Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Doing a media fast provides many benefits to our physical, mental and spiritual health.

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Two social media video clips on South East youths during the week, attracted deserving attention. In the first was a young man who had been on apprenticeship for seven years and was being rewarded ...

New Texas Tech University Health Sciences Center Professor and Chairman of the Psychiatry Department Dr. Rajendra Badgaiyan was drawn to the Permian Basin by the new behavioral health hospital being ...

Minnesota legislators want to legalize and regulate sports gambling, but gambling addiction advocates are advising caution. ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

If you've been dealing with jumping thoughts and a dash of forgetfulness, you could be experiencing what experts have dubbed ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Getting to sleep with a migraine isn’t impossible, it’s just really hard. Try these tips to get the deep-quality sleep you ...

Explore new findings on bipolar disorder, from genetics to sleep patterns, plus emerging treatments and a neuroscientist’s ...

The Pulitzer Prize-winning science writer talks about burnout from covering the pandemic and how bird-watching gave him a new ...